We recently published a list of Jim Cramer Recently Discussed These 15 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer discussed recently.
A caller highlighted Pfizer Inc.’s promising drug pipeline, including multiple phase three candidates and a recent licensing deal with a Chinese biotech company. Cramer agreed and gave his blessing:
“Oh, they are. You know something, David, I’m with you. 7% yield. It’s got to be something big coming out of that Seagen acquisition real soon about some hard to beat cancers. I am with Albert Bourla and I am with you. I think we can own the stock of Pfizer.”
A medical technician wearing protective gloves and a mask mixing a biopharmaceutical solution.
Pfizer Inc. is a global pharmaceutical company best known for its vaccines and innovative therapies in oncology, immunology, and rare diseases.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
This article is originally published at Insider Monkey.
